Risultati della ricerca

• 1. Seminari del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE (100%)

  9-mag-2016 9.00.24

  Seminari del Dottorato di ricerca in BIOMEDICINA E NEUROSCIENZE bionec, dottorato, Biomedicina, Neuroscienze, fulvestrant, anticancer therapy, YopH, Yersinia pestis Mercoledì 11 Maggio 2016 a partire dalle ore 14:00 nell’aula Nesci della Sezione di Anatomia del Dipartimento BioNeC (presso il Policlinico Universitario), si terranno due seminari organizzati nell’ambito delle attività didattiche ... (2-methoxyestradiol, fulvestrant) and polyphenols of olive oil in anticancer therapy". - Dr

• 2. SEMINAR_5-11-2016 (80%)

  6-mag-2016 8.58.43

  oil in anticancer therapy

• 3. cv prof. daniele santini (39%)

  14-apr-2022 16.41.15

• 4. CV_CONCETTA_GIANCOLA (30%)

  17-apr-2020 12.00.54

  -drug recognition in anticancer therapy”. Current Cancer Drug Targets (2007), 7(6), 520-540 ... , Barone G, Giancola C. “Quadruplex-forming oligonucleotides as tools in anticancer therapy and

• 5. giancola_cv (30%)

  22-apr-2020 14.19.47

  in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo ... oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current

• 6. cv prof. giancola (30%)

  14-apr-2022 16.51.45

  oligonucleotides as tools in anticancer therapy and aptamers design: Energetic aspects” Current Medicinal ... ), 16048-16056. 54. Pagano B, Giancola C*. “Energetics of quadruplex-drug recognition in anticancer therapy” Current Cancer Drug Targets (2007), 7, 520-540. 55. Virno A, Randazzo A, Giancola C

• 7. Progetti di ricerca (30%)

  17-ott-2024 16.45.13

  Schiff-base metal complexes as selective G-quadruplex DNA binders for targeted anticancer therapy ... Smart Anticancer Therapy: design of new DNA G-quadruplex stabilizers and their delivery by Receptor

• 8. biosketch_alcaro_jan_19 (24%)

  10-apr-2020 10.33.26

  Grant FIRB on the project "New agents in the specific anticancer therapy". Role: PI

• 9. Progetti di Ricerca 2015 (24%)

  26-apr-2021 15.33.45

  anticancer therapy BARONE Giampaolo 12509 2015-NAZ-0018 NAZ_ALTRO 2015 DRUG DELIVERY: VEICOLI

• 10. Progetti di Ricerca 2014 (24%)

  26-apr-2021 15.35.29

  Anticancer Therapy: design of new DNA G-quadruplex stabilizers and their delivery by Receptor-targeted

• 11. Esiti - Verbale n. 1 del 01.02.2021 (24%)

  5-feb-2021 9.09.14

  for metal complexes in anticancer therapy” – MultiAct - Responsabile Scientifico UNIPA, Prof

• 12. Progetti di Ricerca 2015 (24%)

  6-mar-2017 15.35.27

  anticancer therapy BARONE Giampaolo 12509 2015-NAZ-0018 NAZ_ALTRO 2015 DRUG DELIVERY: VEICOLI

• 13. Progetti di Ricerca 2014 (24%)

  6-mar-2017 15.43.19

  Anticancer Therapy: design of new DNA G-quadruplex stabilizers and their delivery by Receptor-targeted

• 14. cv_santillo (24%)

  31-mag-2023 11.02.37

  pathway of cholesterol and isoprenoids in human colorectal cancer: pathway inhibitors in anticancer therapy.” funded from Ministry of Health, 2000/2001 ADDITIONAL INFORMATION Projects

• 15. l1-cv-galizia (21%)

  16-apr-2020 10.35.00

  Therapeutics Drugs European Journal of Surgical Oncology Expert Review of Anticancer Therapy Expert

• 16. stefano_alcaro_may_17 (21%)

  7-nov-2017 14.22.33

  in the specific anticancer therapy". Role: PI of local unit 2009 Grant MIUR on the project "

• 17. Trial clinici (21%)

  25-lug-2023 12.34.14

  is therefore a promising anticancer therapy and a new tool for oncologists. Evidence from bio-gerontology

• 18. cv 2023 Carreca Anna Paola (21%)

  28-mar-2023 15.24.54

  , Expert Review of Anticancer Therapy, 15:3, 317-330, DOI: 10.1586/14737140.2015.992785, Im pact Factor

• 19. Trial clinici (21%)

  27-lug-2023 10.48.43

  levels. Targeting the IGF system is therefore a promising anticancer therapy and a new tool

• 20. cv prof. nicolai (17%)

  6-apr-2022 11.17.34

  Head & Neck  European Journal of Cancer  Expert Review of Anticancer Therapy  Head and